| CLARISCAN ACIDE GADOTERIQUE |
SOLUTION INJECTABLE 0.5MMOLE/ML |
B/01 FL OU DE B/10 FL (10ML - 15ML - 20ML) |
Liste I |
GE |
GE HEALTHCARE SAS FRANCE |
08 A 002 |
Disponible
|
| CONTRAPAQUE 300 IOHEXOL |
SOLUTION INJECTABLE I =300MG/ML (647MG/ML) |
B/1FL.DE 100ML |
Liste I |
GE |
UNIQUE PHARMACEUTICAL INDE |
08 C 017 |
Disponible
|
| CONTRAPAQUE 350 IOHEXOL |
SOLUTION INJECTABLE I =350MG/ML |
B/01 FL DE 100ML |
Liste I |
GE |
UNIQUE PHARMACEUTICAL INDE |
08 C 018 |
Disponible
|
| DOTAREM ACIDE GADOTERIQUE |
SOLUTION INJECTABLE 0,27932 G(0,5MMOL/ML) |
FL/10 ML - FL/15ML - FL/20ML |
Liste I |
RE |
GUERBET FRANCE |
08 A 002 |
Disponible
|
| GADOVIST GADOBUTROL |
SOLUTION INJECTABLE IV 604,72MG/ML (SOIT 157,25MG/ML EN GADOLINIUM) |
FL./7,5ML - FL./15ML |
Liste I |
RE |
BAYER PHARMA AG ALLEMAGNE |
08 A 069 |
Disponible
|
| GASTROGRAFINE AMIDOTRIZOATE DE SODIUM/AMIDOTRIZOATE DE MEGLUMINE |
SOL.BUV. OU REC. (APPLIC. GASTRO-INTESTINALE) I =370MG/ML (10G/66G/100ML) |
B/1FL. DE 100ML |
Liste I |
RE |
BAYER PHARMA AG ALLEMAGNE |
08 C 008 |
Disponible
|
| HEXABRIX 320 IOXAGLATE DE SODIUM ET DE MEGLUMINE |
SOL INJ INTRA-VASC. - INTRA-UTERINE -INTRA-ARTICULAIRE I=320MG/ML |
FL /20 ML +FL /100 ML |
Liste I |
RE |
GUERBET FRANCE |
08 C 065 |
Arrêt de commercialisation
|
| ILLUSOF IOHEXOL |
SOLUTION INJECTABLE I =300MG/ML (647MG/ML) |
B/1FL.DE 50ML |
Liste I |
GE |
TABUK PHARMACEUTICALS MANUFACTURING COMPANY ARABIE SAOUDITE |
08 C 017 |
Disponible
|
| ILLUSOF IOHEXOL |
SOLUTION INJECTABLE I =350MG/ML |
B/01FL.DE 50ML |
Liste I |
GE |
TABUK PHARMACEUTICALS MANUFACTURING COMPANY ARABIE SAOUDITE |
08 C 018 |
Disponible
|
| IVEPAQUE IOPENTOL |
SOL.INJ I =300MG/ML |
FL/100 ML et F/50ML |
Liste I |
RE |
NYCOMED IMAGING AS NORVEGE |
08 C 050 |
Arrêt de commercialisation
|
| IVEPAQUE IOPENTOL |
SOL.INJ I =350MG/ML |
FL/100 ML et F/50ML |
Liste I |
RE |
NYCOMED IMAGING AS NORVEGE |
08 C 051 |
Arrêt de commercialisation
|
| MAGNEVIST GADOPENTATE DE DIMEGLUMINE |
SOL. INJ. IV 469,01MG/ML** (0,5MMOL/ML)** |
1FL. DE 10ML - 1FL. DE 15ML -1FL. DE 20ML |
Liste I |
RE |
BAYER PHARMA AG ALLEMAGNE |
08 A 001 |
Arrêt de commercialisation
|
| MICROPAQUE BARYUM SULFATE |
SUSP.BUV.OU RECT. 1MG/ML |
FL/150ML- FL/2L |
OTC |
RE |
GUERBET FRANCE |
08 B 004 |
Arrêt de commercialisation
|
| MICROPAQUE SCANNER BARYUM SULFATE |
SUSP. BUV. A DILUER 5G/100ML |
FL/500ML contenant 150ml de susp.à diluer. |
OTC |
RE |
GUERBET FRANCE |
08 B 066 |
Arrêt de commercialisation
|
| OMNIPAQUE IOHEXOL |
SOLUTION INJECTABLE I =300MG/ML |
B/1FL.50ML ET 100ML |
Liste I |
RE |
GE HEALTHCARE AS NORVEGE |
08 C 017 |
Disponible
|
| OMNIPAQUE IOHEXOL |
SOLUTION INJECTABLE I =350MG/ML |
B/01 FL DE 50 ML ET B/01 FL DE 100ML |
Liste I |
RE |
GE HEALTHCARE AS NORVEGE |
08 C 018 |
Disponible
|
| OMNIPOL IOHEXOL |
SOLUTION INJECTABLE I =350MG/ML |
B/01 FL DE 50 ML ET B/01 FL DE 100ML |
Liste I |
GE |
POLIFARMA OLAÇ SAN.VE TIC.AS TURQUIE |
08 C 018 |
Disponible
|
| OMNISCAN GADODIAMIDE |
SOL.INJ I.V I =287MG/ML (OU 0,5MMOL/ML) |
FL/10 ML - 15ML - 20ML |
Liste I |
RE |
GE HEALTHCARE AS NORVEGE |
08 A 039 |
Arrêt de commercialisation
|
| OPTIRAY 300 IOVERSOL |
SOL INJ I=300MG/ML |
FL/50ML - 100ML |
Liste II |
RE |
GUERBET FRANCE |
08 C 053 |
Arrêt de commercialisation
|
| OPTIRAY 350 IOVERSOL |
SOL INJ I=350MG/ML |
FL/50ML - 100ML |
Liste II |
RE |
GUERBET FRANCE |
08 C 054 |
Arrêt de commercialisation
|
| PAMIDOL 300 IOPAMIDOL |
SOLUTION INJECTABLE I =300MG/ML |
FL./50ML - FL./100ML |
Liste I |
GE |
UNIQUE PHARMACEUTICAL INDE |
08 C 020 |
Disponible
|
| PAMIDOL 370 IOPAMIDOL EN IODE ELEMENT |
SOLUTION INJECTABLE I =370MG/ML |
FL./50ML - FL./100ML |
Liste I |
GE |
UNIQUE PHARMACEUTICAL INDE |
08 C 021 |
Disponible
|
| PERSANTINE DIPYRIDAMOLE |
SOL.INJ. IV 10MG/2ML |
B/10 |
Liste I |
RE |
GLENWOOD GMBH ALLEMAGNE |
08 F 034 |
Disponible
|
| RADIOSELCTAN URINAIRE ET VASCULAIRE 76% AMIDOTRIZOATE DE SODIUM/AMIDOTRIZOATE DE MEGLUMINE |
SOL.INJ I.V. I= 370MG/ML |
F/60ML |
Liste I |
RE |
SCHERING S.A. FRANCE |
08 C 010 |
Arrêt de commercialisation
|
| RADIOSELECTAN URINAIRE ET VASCULAIRE 76% AMIDOTRIZOATE DE SODIUM / AMIDOTRIZOATE DE MEGLUMINE |
SOL.INJ. IV I=370MG/ML |
F/20ML |
Liste II |
RE |
SCHERING SA FRANCE |
08 C 009 |
Arrêt de commercialisation
|